2m 2m 2m 2m 2m 2m 2m
VYOME HLDGS (HIND)
NASDAQ
$2.20+$0.08 (+4.02%)
Price as of Aug 03, 2026 12:22 PM EDT- $14.8MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
VYOME HLDGS (HIND)
$2.20+$0.08 (+4.02%)
HIND | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.12 | ||
Change | +$0.11 (+5.22%) | ||
Open | $2.03 | ||
High | $2.14 | ||
Low | $2.01 | ||
Previous Close | $2.01 | ||
Volume | 23,252 | ||
30-Day Average Volume | 13,691 | ||
1-Week Change | 2.67% | ||
1-Month Change | -1.63% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 7.0M | ||
Total Assets | $10.2M | ||
Market Cap | $14.8M | ||
Enterprise Value | $16.5M | ||
Period: QTR TTM FY | |||
Revenue | $31,591.00 | ||
Net Income | -$962,910.00 | ||
Free Cash Flow | -$1.4M | ||
EBIT | -$962,910.00 | ||
EBITDA | -$960,305.00 | ||
Net Working Capital | $7.0M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -17 | ||
Enterprise Value/Revenue | 521 | ||
P/B | 2 | ||
P/E | -14 | ||
PEG | 6 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 08/15/2025 | ||
Earnings & Revenue